Revenues | |
Grant revenues | |
Operating expenses | |
Research and development | 108.67K |
General and administrative | |
Total operating expenses | 1.19M |
Loss from operations | -1.19M |
Change in fair value of derivative liabilities | |
Gain on warrant exchange | |
Interest income | |
Interest expense | -2.11K |
Net loss from continuing operations | |
Net loss from discontinued operations | |
Gain on sale of business unit | |
Net loss | -1.19M |
Loss per common share - basic and diluted | -0.14 |
Weighted average common shares outstanding |